[1] Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chinese Journal of Diabetes, 13, 315-409(2021).

[2] Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both?[J]. Current Diabetes Reports, 14, 1-10(2013).

[3] Cai W, Ramdas M, Zhu L et al. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1[J]. Proceedings of the National Academy of Sciences of the United States of America, 109, 15888-15893(2012).

[4] Nowotny K, Jung T, Höhn A et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus[J]. Biomolecules, 5, 194-222(2015).

[5] Coughlan M T, Yap F Y, Tong D C et al. Advanced glycation end products are direct modulators of β-cell function[J]. Diabetes, 60, 2523-2532(2011).

[6] Waateringe R P, Fokkens B T, Slagter S N et al. Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population[J]. Diabetologia, 62, 269-280(2019).

[7] Ye C S, Wang Y K, Ye S D. Property and detection of advanced glycation end products[J]. International Journal of Pathology and Clinical Medicine, 33, 175-178(2013).

[8] Zhang Y, Ni J S, Zhang Y Z et al. Tissue intrinsic fluorescence spectrum recovery algorithm and its application in diabetes screening[J]. Chinese Journal of Lasers, 45, 0707001(2018).

[9] Meerwaldt R, Graaff R. Oomen P H N, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation[J]. Diabetologia, 47, 1324-1330(2004).

[10] Cleary P A, Braffett B H, Orchard T et al. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study[J]. Diabetes Technology & Therapeutics, 15, 466-474(2013).

[11] Franco W, Gutierrez-Herrera E, Kollias N et al. Review of applications of fluorescence excitation spectroscopy to dermatology[J]. The British Journal of Dermatology, 174, 499-504(2016).

[12] Gillies R, Zonios G, Anderson R R et al. Fluorescence excitation spectroscopy provides information about human skin in vivo[J]. Journal of Investigative Dermatology, 115, 704-707(2000).

[13] Beisswenger P J, Howell S. MacKenzie T, et al. Two fluorescent wavelengths, 440ex/520em nm and 370ex/440em nm, reflect advanced glycation and oxidation end products in human skin without diabetes[J]. Diabetes Technology & Therapeutics, 14, 285-292(2012).

[14] Zuo Z L, Zhao N J, Meng D S et al. Identification of petroleum organic matter in soil based on three-dimensional fluorescence spectroscopy[J]. Laser & Optoelectronics Progress, 56, 222601(2019).

[15] Zhang Y Z, Hou H Y, Zhang Y et al. Tissue intrinsic fluorescence recovering by an empirical approach based on the PSO algorithm and its application in type 2 diabetes screening[J]. Biomedical Optics Express, 9, 1795-1808(2018).

[16] Hennessy R, Lim S L, Markey M K et al. Monte Carlo lookup table-based inverse model for extracting optical properties from tissue-simulating phantoms using diffuse reflectance spectroscopy[J]. Journal of Biomedical Optics, 18, 037003(2013).

[17] Feng W, Shi R, Zhang C et al. Lookup-table-based inverse model for mapping oxygen concentration of cutaneous microvessels using hyperspectral imaging[J]. Optics Express, 25, 3481-3495(2017).

[18] Liu Y, Zhang Y Z, Hou H Y et al. Tissue intrinsic fluorescence spectrum recovering based on diffusion theory[J]. Spectroscopy and Spectral Analysis, 36, 3836-3841(2016).

[19] Hu Y, Fu Y, Li X Y et al. Fluorescence spectra and fluorescence saturation intensity analysis of hepatic cell, hepatoma carcinoma cell and hepatic fibrosis cell[J]. Spectroscopy and Spectral Analysis, 40, 478-482(2020).

[20] Li T T, Yang F, Li S G et al. Extraction method of line-structured light stripe center based on Gauss-Lorenz decomposition peak fitting[J]. Laser & Optoelectronics Progress, 56, 071201(2019).

[21] Chinese Association of Diabetes. Chinese experts consensus for drug therapy of microcirculatory dysfunction in diabetes mellitus: 2021 updated[J]. Chinese Journal of the Frontiers of Medical Science (Electronic Version), 13, 49-57(2021).

[22] Li B X, Zhang Y L, Zhang X et al. Changes of serum leptin and α-MSH levels in type 2 diabetes patients complicating with different grades of hypertension[J]. Chinese Circulation Journal, 33, 851-855(2018).